Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Measuring InstrumentBiotechnology Equipment

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1786342

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1786342

CRO Mass Spectroscopy Services

PUBLISHED:
PAGES: 280 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global CRO Mass Spectroscopy Services Market to Reach US$2.2 Billion by 2030

The global market for CRO Mass Spectroscopy Services estimated at US$930.0 Million in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 15.7% over the analysis period 2024-2030. Proteomics Services, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Metabolomics Services segment is estimated at 14.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$253.4 Million While China is Forecast to Grow at 20.9% CAGR

The CRO Mass Spectroscopy Services market in the U.S. is estimated at US$253.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$486.6 Million by the year 2030 trailing a CAGR of 20.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.5% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Global CRO Mass Spectroscopy Services Market - Key Trends & Drivers Summarized

Why Are CRO Mass Spectroscopy Services in High Demand? Exploring the Need for Advanced Analytical Testing

The global contract research organization (CRO) mass spectroscopy services market is expanding rapidly due to the increasing complexity of drug development, stringent regulatory requirements, and the growing demand for high-precision analytical testing in pharmaceutical and biotechnology industries. Mass spectrometry is a crucial technique for identifying chemical compounds, detecting impurities, and characterizing biomolecules with high sensitivity and accuracy. As biopharmaceutical companies focus on improving drug safety and efficacy, outsourcing analytical testing to CROs has become a cost-effective solution. The rise of personalized medicine, biosimilars, and complex biologics has further driven the demand for specialized mass spectrometry services.

Which Mass Spectroscopy Services Are Leading the CRO Market? A Breakdown of Key Segments

The CRO mass spectroscopy services market includes various specialized analytical techniques tailored for different research and regulatory needs. Liquid chromatography-mass spectrometry (LC-MS) is widely used for drug discovery, pharmacokinetics, and metabolomics studies. Gas chromatography-mass spectrometry (GC-MS) remains a key technique for environmental and forensic testing, as well as volatile compound analysis. High-resolution mass spectrometry (HRMS) and tandem mass spectrometry (MS/MS) are essential for proteomics and biomarker discovery. Additionally, mass spectrometry imaging (MSI) is gaining traction in biomedical research for tissue analysis and disease profiling. The integration of automation and AI-driven data analysis has further enhanced mass spectrometry capabilities, improving throughput and precision.

How Is Technology Transforming CRO Mass Spectrometry Services? The Role of AI, Automation & Real-Time Analysis

The CRO mass spectrometry industry is evolving with technological advancements in AI-driven data processing, automation, and real-time molecular analysis. AI-powered mass spectrometry software has improved spectral interpretation, reducing the time required for complex compound identification. The development of real-time mass spectrometry techniques, such as ambient ionization mass spectrometry, has enabled faster sample analysis in clinical and pharmaceutical applications. Additionally, automation in sample preparation and high-throughput screening has enhanced efficiency and scalability in CRO laboratories. Cloud-based data management solutions have also facilitated remote collaboration and regulatory compliance, ensuring seamless access to analytical results across global research teams.

What’s Driving the Growth of the CRO Mass Spectrometry Services Market? Key Market Influencers Explained

The growth in the CRO mass spectrometry services market is driven by increasing pharmaceutical R&D investments, rising regulatory scrutiny, and the demand for high-precision bioanalytical testing. The expansion of biologics and gene therapy research has created new opportunities for CROs specializing in mass spectrometry-based biomolecular analysis. Additionally, the growing need for quality control in food safety, environmental monitoring, and forensic science has broadened market applications. The shift toward contract-based research outsourcing has allowed pharmaceutical companies to streamline their drug development processes, further strengthening the CRO mass spectrometry sector. With continuous technological advancements and increasing analytical requirements, the market is expected to experience sustained growth in the coming years.

SCOPE OF STUDY:

The report analyzes the CRO Mass Spectroscopy Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (Proteomics Services, Metabolomics Services, Other Services); End-Use (Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • 360biolabs
  • ABC Laboratories
  • Accurant Biotech
  • ACM Global Laboratories
  • Active Biomarkers
  • Alderley Analytical
  • Alliance Pharma
  • Allumiqs
  • Altasciences
  • Analytik Jena
  • BioAgilytix
  • Charles River Laboratories
  • CovalX
  • Creative Proteomics
  • Labcorp Drug Development
  • MS Bioworks
  • Novatia
  • Omics Solutions
  • PPD Laboratories
  • Waters Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP30294

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • CRO Mass Spectroscopy Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for High-Precision Analytical Services Drives Growth in CRO Mass Spectrometry Services
    • Surge in Biopharmaceutical and Biotechnology Research Expands Addressable Market for Mass Spectrometry in Drug Development
    • Rising Complexity of Drug Discovery and Development Processes Strengthens Business Case for Advanced Mass Spectrometry Solutions
    • Technological Advancements in Mass Spectrometry Instrumentation Drive Market Innovation and Demand for Outsourced Services
    • Growing Focus on Personalized Medicine and Targeted Therapies Accelerates the Need for Advanced Mass Spectrometry in Clinical Trials
    • Expansion of Proteomics and Metabolomics Research Generates New Opportunities for CRO Mass Spectrometry Services
    • Increasing Investment in R&D by Pharmaceutical Companies Spreads Demand for Mass Spectrometry Services in Drug Discovery
    • The Integration of Mass Spectrometry with Other Analytical Techniques Expands Market Opportunity for Multi-Technique Research Solutions
    • The Rising Popularity of Biomarker Discovery Drives Accelerated Demand for Mass Spectrometry in Clinical and Translational Research
    • Advancements in Quantitative Mass Spectrometry and Data Analysis Strengthen the Business Case for Accurate, Reproducible Results
    • Increasing Demand for High-Throughput and Automation in Research Drives Growth in Mass Spectrometry Service Offerings
    • Regulatory Pressures for Enhanced Safety and Efficacy of Drugs Strengthens the Case for Mass Spectrometry in Compliance Testing
    • Rising Demand for Environmental and Food Safety Testing Expands Market for CRO Mass Spectrometry Services in Non-Pharma Sectors
    • The Growth of Contract Research Organizations (CROs) in Emerging Markets Expands the Global Reach of Mass Spectrometry Services
    • Focus on Reducing Drug Development Costs and Time-to-Market Drives Adoption of CRO Mass Spectrometry Services in Early-Stage Research
    • Increasing Complexity of Biologics and Biosimilars Development Propels Market Demand for Mass Spectrometry in Protein Analysis
    • The Integration of Artificial Intelligence and Machine Learning with Mass Spectrometry Services Generates New Analytical Capabilities
    • The Need for High-Quality and Comprehensive Data in Clinical Trials Propels Demand for Advanced Mass Spectrometry in Regulatory Submissions
    • Heightened Interest in Translational Medicine and Diagnostics Creates Opportunities for Mass Spectrometry in Disease Biomarker Research
    • The Rise in Outsourcing Analytical Services by Pharmaceutical Companies Expands Market for CRO Mass Spectrometry Service Providers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World CRO Mass Spectroscopy Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for CRO Mass Spectroscopy Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Proteomics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Proteomics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Proteomics Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Metabolomics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Metabolomics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Metabolomics Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceutical & biopharmaceutical companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pharmaceutical & biopharmaceutical companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Pharmaceutical & biopharmaceutical companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Medical device companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Medical device companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Medical device companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for CRO Mass Spectroscopy Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for CRO Mass Spectroscopy Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for CRO Mass Spectroscopy Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • CRO Mass Spectroscopy Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for CRO Mass Spectroscopy Services by Service Type - Proteomics Services, Metabolomics Services and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for CRO Mass Spectroscopy Services by Service Type - Percentage Breakdown of Value Sales for Proteomics Services, Metabolomics Services and Other Services for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for CRO Mass Spectroscopy Services by End-Use - Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for CRO Mass Spectroscopy Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & biopharmaceutical companies End-Use, Medical device companies End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!